The MCP-1 levels in the serum and urine were significantly elevated in SLE patients compared to those in healthy individuals, irrespective of the degree of disease activity and renal involvement, and it can be used as a biomarker for SLE [59]. The gene discussed is CCL2; the disease is systemic lupus erythematosus.